News
- Author:
- Liam Davenport
Publish date: April 6, 2022
In the U.K., approximately 25% of children with type 1 diabetes are diagnosed while they are in diabetic ketoacidosis, a figure that has remained u...
News
- Author:
- Liam Davenport
Publish date: March 31, 2022
For some cancers it was “very clear that obesity increased the risk ... but for some other cancer types, we either don’t have enough data yet or th...
News
- Author:
- Liam Davenport
Publish date: March 31, 2022
The most commonly reported issues were decreased sexual desire, lubrication problems, orgasmic dysfunction, and pain.
News
- Author:
- Liam Davenport
Publish date: March 28, 2022
For patients who are hearing their options for the first time, chemotherapy “feels scary,” and there is “a lot of stigma” associated with it.
News
- Author:
- Liam Davenport
Publish date: March 3, 2022
“This is the first study to demonstrate broad clinical utility and validity of the biomarker in HPV-driven oropha...
News
- Author:
- Liam Davenport
Publish date: January 25, 2022
“For the people who need systemic therapy,” it appears from the current results that BV-CHP “is a very good option.”
News
- Author:
- Liam Davenport
Publish date: January 3, 2022
Breast cancer patients who are incarcerated at diagnosis often do not get neoadjuvant therapy and face delays in upfront surgery, study finds.
News
- Author:
- Liam Davenport
Publish date: January 3, 2022
Combining clinical risk factors with a polygenic risk score accounting for ancestral background substantially improves breast cancer risk predictio...
News
- Author:
- Liam Davenport
Publish date: December 23, 2021
Antibodies against the hormone in mice models prevent type 1 diabetes and improve glycemic control in type 2 dise...
News
- Author:
- Liam Davenport
Publish date: December 16, 2021
The voluntary withdrawal of the type 1 diabetes indication for dapagliflozin in the EU by AstraZeneca has been branded as ‘appalling’ and ‘devastat...
News
- Author:
- Liam Davenport
Publish date: December 15, 2021
Black women may have outcomes comparable to those of other women when given sacituzumab govitecan for the treatment of metastatic TNBC, suggests AS...
News
- Author:
- Liam Davenport
Publish date: December 15, 2021
PD-L1 CPS of at least 10 improves overall survival by 28%-29%. Further analysis of responses to pembrolizumab plus chemotherapy in metastatic TNBC ...
News
- Author:
- Liam Davenport
Publish date: December 15, 2021
Neoadjuvant pembrolizumab benefits early TNBC patients regardless of disease stage and nodal status. Event-free survival improved by about 35% acro...
News
- Author:
- Liam Davenport
Publish date: December 10, 2021
Personalized medicine could be a step closer with the discovery that TNBC and ER+ breast cancers should have different genomic instability threshol...
News
- Author:
- Liam Davenport
Publish date: November 29, 2021
The results will “allow clinicians to better weigh the potential benefits of supplementation against its risk,” such as financial cost.
